Clinical trial
Efficacy of Ethnodyne Visio in Parkinson's Disease
NCT02815800 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Ethnodyne Visio in Parkinson's Disease
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 2, 2016
- Completion date
- March 12, 2018
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease